Stavros G Drakos

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. doi request reprint Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery
    Stavros G Drakos
    Utah Transplantation Affiliated Hospitals UTAH Cardiac Transplant Program, Divisions of Cardiology and Cardiothoracic Surgery, University of Utah Health Sciences Center, Intermountain Medical Center, Salt Lake City, Utah 84132, USA
    J Am Coll Cardiol 61:1985-94. 2013
  2. pmc Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action
    Stavros G Drakos
    UTAH Cardiac Transplant Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Curr Opin Cardiol 26:245-55. 2011
  3. pmc Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart
    Stavros G Drakos
    Cardiovascular Department and Utah Artificial Heart Program, Intermountain Medical Center, Salt Lake City, Utah, USA
    J Am Coll Cardiol 56:382-91. 2010
  4. pmc Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Omar Wever-Pinzon
    U T A H Cardiac Transplant Program, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Circulation 127:452-62. 2013
  5. doi request reprint A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, Utah, USA
    J Heart Lung Transplant 31:46-51. 2012
  6. doi request reprint Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II
    Omar Wever-Pinzon
    Utah Transplantation Affiliated Hospitals, Cardiac Transplant Program, Salt Lake City, UT, USA
    Circ Heart Fail 6:517-26. 2013
  7. ncbi request reprint Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions
    Stavros G Drakos
    Utah Transplantation Affiliated Hospitals UTAH Cardiac Transplant Program, Salt Lake City, Utah, USA
    J Thorac Cardiovasc Surg 133:1612-9. 2007
  8. doi request reprint Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database
    Aaron H Healy
    Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Ann Thorac Surg 95:870-5. 2013
  9. ncbi request reprint Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients
    Stavros G Drakos
    LDS Hospital, University of Utah School of Medicine, Utah Transplantation Affiliated Hospitals Cardiac Transplant Program, Salt Lake City, Utah 84143, USA
    Ann Thorac Surg 82:889-93. 2006
  10. pmc Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization
    Stavros G Drakos
    Utah Transplant Affiliated Hospitals UTAH Cardiac Transplant Program, Salt Lake City, UT 84112, USA
    J Heart Lung Transplant 28:838-42. 2009

Collaborators

Detail Information

Publications22

  1. doi request reprint Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery
    Stavros G Drakos
    Utah Transplantation Affiliated Hospitals UTAH Cardiac Transplant Program, Divisions of Cardiology and Cardiothoracic Surgery, University of Utah Health Sciences Center, Intermountain Medical Center, Salt Lake City, Utah 84132, USA
    J Am Coll Cardiol 61:1985-94. 2013
    ..This study sought to prospectively investigate the longitudinal effects of continuous-flow left ventricular assist device (LVAD) unloading on myocardial structure and systolic and diastolic function...
  2. pmc Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action
    Stavros G Drakos
    UTAH Cardiac Transplant Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Curr Opin Cardiol 26:245-55. 2011
    ..Herein, we summarize and integrate insights from studies which investigated how LVAD unloading influences the structure and function of the failing human heart...
  3. pmc Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart
    Stavros G Drakos
    Cardiovascular Department and Utah Artificial Heart Program, Intermountain Medical Center, Salt Lake City, Utah, USA
    J Am Coll Cardiol 56:382-91. 2010
    ..This study investigates alterations in myocardial microvasculature, fibrosis, and hypertrophy before and after mechanical unloading of the failing human heart...
  4. pmc Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Omar Wever-Pinzon
    U T A H Cardiac Transplant Program, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Circulation 127:452-62. 2013
    ..Survival of patients on left ventricular assist devices (LVADs) has improved. We examined the differences in risk of adverse outcomes between LVAD-supported and medically managed candidates on the heart transplant waiting list...
  5. doi request reprint A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, Utah, USA
    J Heart Lung Transplant 31:46-51. 2012
    ..Debate continues about whether therapeutic intervention is warranted to avoid adverse outcomes. In this study we examine the course of individual episodes of untreated asymptomatic AMR on follow-up endomyocardial biopsy (EMB)...
  6. doi request reprint Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II
    Omar Wever-Pinzon
    Utah Transplantation Affiliated Hospitals, Cardiac Transplant Program, Salt Lake City, UT, USA
    Circ Heart Fail 6:517-26. 2013
    ..Reduced pulsatility has been implicated as a contributing cause. The aim of this study was to assess the effects of different degrees of pulsatility on the incidence of nonsurgical bleeding...
  7. ncbi request reprint Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions
    Stavros G Drakos
    Utah Transplantation Affiliated Hospitals UTAH Cardiac Transplant Program, Salt Lake City, Utah, USA
    J Thorac Cardiovasc Surg 133:1612-9. 2007
    ..We investigated the pattern of sensitization in left ventricular assist device recipients in relation to cellular blood product transfusions received...
  8. doi request reprint Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database
    Aaron H Healy
    Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Ann Thorac Surg 95:870-5. 2013
    ..We sought to determine if the presence or absence of complications in status 1A LVAD patients at the time of transplant influenced survival after transplant...
  9. ncbi request reprint Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients
    Stavros G Drakos
    LDS Hospital, University of Utah School of Medicine, Utah Transplantation Affiliated Hospitals Cardiac Transplant Program, Salt Lake City, Utah 84143, USA
    Ann Thorac Surg 82:889-93. 2006
    ....
  10. pmc Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization
    Stavros G Drakos
    Utah Transplant Affiliated Hospitals UTAH Cardiac Transplant Program, Salt Lake City, UT 84112, USA
    J Heart Lung Transplant 28:838-42. 2009
    ..04). Pre-sensitized patients are at higher risk for becoming and remaining highly HLA-allosensitized after LVAD implantation. The HeartMate II LVAD appears to cause less sensitization than HeartMate I...
  11. doi request reprint Improved survival in heart transplant patients living at high altitude
    Curtis J Wozniak
    Division of Cardiothoracic Surgery, University of Utah, Salt Lake City, UT 84132 2101, USA
    J Thorac Cardiovasc Surg 143:735-741.e1. 2012
    ..The purpose of the present study was to determine whether altitude negatively affects survival among patients undergoing heart transplantation...
  12. doi request reprint Risk factors predictive of right ventricular failure after left ventricular assist device implantation
    Stavros G Drakos
    Cardiovascular Department, Intermountain Medical Center, Salt Lake City, Utah University of Utah School of Medicine, Salt Lake City, Utah, USA
    Am J Cardiol 105:1030-5. 2010
    ....
  13. doi request reprint Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation
    Jose N Nativi
    Department of Medicine, Division of Cardiology, University of Utah, Salt Lake City, Utah 84132, USA
    J Heart Lung Transplant 30:854-61. 2011
    ..Our aim was to determine the impact of the type of LVAD and implant era on post-transplant survival...
  14. ncbi request reprint Effect of reversible pulmonary hypertension on outcomes after heart transplantation
    Stavros G Drakos
    Utah Transplantation Affiliated Hospitals, Cardiac Transplant Program, LDS Hospital, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 26:319-23. 2007
    ..Conflicting data exist regarding the impact of reversible pulmonary hypertension (PHTN) on post-transplant (Tx) outcomes. In this study we sought to determine the influence of reversible PHTN on outcomes after Tx...
  15. doi request reprint Allograft rejection in patients supported with continuous-flow left ventricular assist devices
    Aaron H Healy
    UTAH Utah Transplant Affiliated Hospitals Cardiac Transplant Program, University of Utah, Salt Lake City, Utah 84132, USA
    Ann Thorac Surg 92:1601-7; discussion 1607. 2011
    ..We sought to analyze the relationship between LVAD flow characteristics and subsequent allograft rejection in bridge to transplant (BTT) patients...
  16. doi request reprint Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, UT, USA
    J Heart Lung Transplant 28:781-4. 2009
    ..In this study, we examined whether a differential impact on cardiovascular mortality (CVM) existed when comparing asymptomatic AMR, to stable MR or CR...
  17. ncbi request reprint Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support
    Stavros G Drakos
    LDS Hospital, Salt Lake City, Utah 84143, USA
    Ann Thorac Surg 83:62-7. 2007
    ..Determining which pretransplantation (TX) characteristics predict the development of chronic renal dysfunction (CRD) or death after heart TX would enable more accurate risk assessment at the time of candidate evaluation...
  18. pmc Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice
    Aubrey C Chan
    Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA
    J Clin Invest 121:1871-81. 2011
    ..These results suggest that CCM may be more effectively treated by directing therapies based on the underlying genetic mutation rather than treating the condition as a single clinical entity...
  19. ncbi request reprint Ventricular-assist devices for the treatment of chronic heart failure
    Stavros G Drakos
    University of Athens Medical School, 3rd Department of Cardiology, Laiko Hospital, Athens, Greece
    Expert Rev Cardiovasc Ther 5:571-84. 2007
    ....
  20. pmc Vascular leak is a central feature in the pathogenesis of systemic sclerosis
    Tracy M Frech
    Division of Rheumatology, Department of Internal Medicine, University of Utah, 4B200 SOM, 30 N 1900 E, Salt Lake City, Utah 84132, USA
    J Rheumatol 39:1385-91. 2012
    ..We investigated the microvasculature alterations in the skin of patients with SSc at various stages of disease duration with whole-field digital microscopy...
  21. ncbi request reprint Effect of mechanical circulatory support on outcomes after heart transplantation
    Stavros G Drakos
    Utah Transplantation Affiliate Hospitals Cardiac Transplant Program, Salt Lake City, UT, USA
    J Heart Lung Transplant 25:22-8. 2006
    ....
  22. pmc The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases
    Kevin J Whitehead
    Division of Cardiology, Department of Medicine, 30 North 1900 East, Room 4A100, University of Utah, Salt Lake City, Utah 84132, USA
    Nat Med 15:177-84. 2009
    ..These data offer the prospect for pharmacological treatment of a human vascular dysplasia with a widely available and safe drug...